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A B S T R A C T
Tuberculosis has been suggested as an independent risk factor for thromboembolism due to a hypercoagulable state induced by changes in clotting factors, protein C
and vascular endothelium. Pulmonary vein thrombosis (PVT) is a rare, potentially serious and life-threatening condition that can be caused by tuberculosis. Its rare
occurrence is due to a rich network of venous collateral vessels that drain the lung. PVT can also occur following lobectomy for malignancy, lung transplantation,
radiofrequency catheter ablation for atrial fibrillation, sclerosing mediastinitis and following metastatic cancer, such as liposarcoma. Pulmonary vein thrombosis is
difficult to diagnose clinically and requires a combination of conventional diagnostic modalities. Systemic anticoagulation, treatment of the predisposing pathology
and monitoring of the thrombosis are parts of management of pulmonary vein thrombosis. We present a case of pulmonary vein thrombosis due to tuberculosis. Our
patient is a 67-year-old Caucasian male with a past medical history significant for hypertension and hyperlipidemia who came to our hospital with hemoptysis, cough
and shortness of breath 1-month duration. He also noticed around 20 pounds of weight loss and night sweats but had no fever. He had no history of travel outside the
USA and has never been incarcerated before, but he endorsed that his son has been in Jail before but the son has never been diagnosed with TB. He quit smoking 2
months ago. He was tachycardic, tachypneic and had decreased air entry with crepitation in the right side of the posterior chest. Chest x ray showed multiple cavitary
lesions in the right upper lobe area. CT scan of the chest with contrast showed pulmonary venous partial thrombosis in the right upper lobe with multiple cavitary
lesions with hilar and mediastinal lymphadenopathy. Sputum AFB was positive for mycobacterium tuberculosis and was sensitive for rifampicin. Patient was treated
with systemic anticoagulation and anti-tuberculosis medications. Patient’s hospital course was complicated by development of elevated liver enzymes at which time
the anti-TB medications were stopped to be restarted one by one with a follow up of his liver enzymes and liver function tests. Our case shows that presentation of
patients with PVT is non-specific and needs a very high index of suspicion for proper diagnosis and management to prevent further complications as it is associated
with limb and life-threatening complications. It also illustrates the importance of considering PVT in a patient with tuberculosis.
1. Introduction
About 30 percent of the world population are estimated to be in-
fected with mycobacterium tuberculosis [1–3]. Tuberculosis has been
suggested as an independent risk factor for thromboembolism due to a
hypercoagulable state induced by changes in clotting factors, protein C
and vascular endothelium [4,5]. Pulmonary vein thrombosis (PVT) is a
rare, potentially serious and life-threatening condition that can be
caused by tuberculosis. Its rare occurrence is due to a rich network of
venous collateral vessels that drain the lung [6–8]. PVT can also occur
following lobectomy for malignancy, lung transplantation, radio-
frequency catheter ablation for atrial fibrillation, sclerosing mediasti-
nitis and following metastatic cancer, such as liposarcoma [9–11].
Pulmonary vein thrombosis is difficult to diagnose clinically and re-
quires a combination of conventional diagnostic modalities. Systemic
anticoagulation, treatment of the predisposing pathology and mon-
itoring of the thrombosis are parts of management of pulmonary vein
thrombosis [8]. We present a case of pulmonary vein thrombosis due to
tuberculosis.
2. Case presentation
Our patient is a 67-year-old male with a past medical history sig-
nificant for hypertension and hyperlipidemia who came to our hospital
with hemoptysis. He was also having cough and shortness of breath for
the last 1 month. He said that his hemoptysis was about 1 cup per day
mixed with yellowish sputum. He noticed around 20 pounds of weight
loss in the last 1 month. He also complained of night sweats but had no
fever. He had no history of travel outside the USA. He has never been
incarcerated before, but he endorsed that his son has been in Jail before
and he visited him twice a year in patient's home. But he also said that
his son has never been diagnosed with TB. He smoked 1.5 packs per day
for the last 50 years and quit smoking 2 months ago. His medication
includes hydrochlorothiazide, lisinopril, gabapentin, aspirin and
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trazodone. On examination, vital signs were within the normal range
except a heart rate of 106 beats/minute. He had slightly pale con-
junctiva, non-icteric sclera and had wet tongue and buccal mucosa.
There was decreased air entry with crepitations in the right side of the
posterior chest but no wheezes or rales. No peripheral lymphadeno-
pathy, no peripheral edema or sign of fluid collection in the abdomen.
Chest x ray (Fig. 1) showed multiple cavitary lesion in the right
upper lobe area. CT scan of the chest with contrast (Figs. 2 and 3)
showed pulmonary venous partial thrombosis in the right upper lobe.
Multiple cavitary lesions with hilar and mediastinal lymphadenopathy.
There are also smaller nodular lesions in the left chest too. Small right
pleural effusion with multiple calcified granulomata in the left upper
lobe. QuantiFERON gold test was found to be positive. Sputum AFB
smear was found to be strongly positive and it is sensitive to rifampin.
Echocardiography showed no valvular lesions with preserved ejection
fraction (> 65%) and normal right ventricular size and normal right
ventricular systolic pressure. Liver enzymes and renal function tests
were found within the normal limit. HIV test was negative. Patient was
started with intensive phase anti-tuberculosis treatment with rifampin,
isoniazid, ethambutol, pyrazinamide with vitamin B6. He was also
started with anticoagulation with heparin and warfarin considering the
tuberculosis being the cause of the pulmonary vein thrombosis. Patient
was also given supportive treatment and he made a gradual improve-
ment and was discharged with anti-tuberculosis treatment and war-
farin. Patient needed to be placed on a higher dose of warfarin as it was
difficult to keep him therapeutic with lower doses. He was also advised
to follow with infectious disease and anticoagulation clinic. Patient was
found to have a significant increase in liver enzymes and bilirubin on
follow up and the anti-TB medications were stopped to be restarted one
by one with a follow up of his liver enzymes and liver function tests. He
was also continued with warfarin.
3. Discussion
More than two billion people, about 30 percent of the world po-
pulation, are estimated to be infected with mycobacterium tuberculosis.
The global incidence of tuberculosis (TB) peaked around 2003 and
appears to be declining slowly. According to the World Health
Organization (WHO), in 2016, 10.4 million individuals became ill with
TB and 1.7 million died [1]. Poverty, human immunodeficiency virus
(HIV), and drug resistance are major contributors to the resurging
global TB epidemic. Approximately 95 percent of TB cases occur in
developing countries (2). Around 70% of TB cases in the United States
now occurs in foreign-born individuals emigrating from countries with
high rates of endemic TB [3]. Tuberculosis, both pulmonary and ex-
trapulmonary, has been suggested as an independent risk factor for
venous thromboembolism (VTE), perhaps due to a hypercoagulable
state.
In one retrospective study including 3485 cases of active TB, the
prevalence of VTE was approximately 2 percent, which is similar to the
rate associated with malignancy and approximately 100 times higher
than the incidence of VTE among hospitalized patients in general [4,5].
Previous studies have shown that there is high level of plasma fi-
brinogen with impaired fibrinolysis, low level of antithrombin III and
protein C which induce a hypercoagulable state and thus more
thrombosis. It has also been shown that there is significant decrease of
prothrombin levels in one third of tuberculosis patients which also
further exposes TB patients to thrombosis [8,9]. The other theory
suggested in literature as to the cause of thrombosis in TB is the cyto-
kine theory where cytokines are proinflammatory and activate the
vascular intima and make the endothelium more thrombogenic [9].
Some authors have postulated that various local factors may lead to
thrombosis such as from venous compression by lymph nodes, as
mediastinal and retroperitoneal lymphadenopathies may cause chest or
inferior vena cava thrombosis in the absence of any hemostatic ab-
normalities. However, there are also literatures suggesting that sys-
temic rather than local factors play a predominant role [6]. There are
case reports on different types of thrombosis in literature related to
tuberculosis including extremity deep venous thrombosis, portal vein
thrombosis, hepatic vein thrombosis and superior sagittal vein throm-
bosis [10–12]. Our patient presented with pulmonary vein thrombosis
with a newly diagnosed tuberculosis. Pulmonary vein thrombosis is a
rare condition. The incidence is unclear, as most of the literature in-
cludes case reports. The majority of cases are reported following lo-
bectomy for malignancy, lung transplantation, radiofrequency catheter
ablation for atrial fibrillation, sclerosing mediastinitis and following
metastatic cancer, such as liposarcoma. Idiopathic cases of pulmonary
vein thrombosis are also described in a literature. Most patients with
PVT are commonly asymptomatic or have nonspecific symptoms such
as cough, hemoptysis, and dyspnea from pulmonary edema or
Fig. 1. Chest X ray.
Fig. 2. CT scan showing the pulmonary vein thrombosis.
Fig. 3. CT scan picture showing the TB lesions and pulmonary vein thrombosis.
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infarction. In majority of cases, pulmonary artery pressure increases
concomitant with systemic hypotension and low cardiac output. Re-
spiratory parameters also deteriorate, including worsening oxygena-
tion, hypercapnia, and decreasing pulmonary compliance. Our patient
presented with mild hemoptysis and shortness of breath but didn't have
any hemodynamic abnormality other than a tachycardia of 106 beats
per minute [8]. Our patient also didn't have an increase in pulmonary
artery pressure. This can be explained by the partial nature of pul-
monary vein obstruction seen in our patient. He was also having cough
with yellowish sputum.
The coexistence of tuberculosis and pulmonary vein thrombosis in
our patient will make it very difficult to say that a symptom is caused by
TB or PVT as it could also be the other one causing the same symptom.
One case report in literature described a presentation of tuberculosis
with pulmonary vein thrombosis with atrial extension which we didn't
see in our patient [13]. Post-operative, Malignancy and radiofrequency
catheter ablation related pulmonary vein thromboses have a dramatic
presentation with hemodynamic instability and it requires prompt di-
agnosis and intervention due to high mortality. The relatively stable
presentation of our patient is due to the incomplete obstruction and the
fact that the patient might have presented early, and this type of non-
specific presentation needs a high index of suspicion for the condition
and proper investigation and management to prevent further compli-
cations. Pulmonary vein thrombosis is difficult to diagnose clinically
and requires a combination of conventional diagnostic modalities.
Pulmonary venous phase of a contrast CT of the chest is used to diag-
nose pulmonary vein thrombosis and our patient was diagnosed while
undergoing a contrast CT scan. In literature, a trans esophageal echo-
cardiogram (TEE) can also be used to diagnose it and TEE may de-
monstrate extension of a thrombus into the atrium if it is present. In
malignancy associated pulmonary vein thrombosis, Magnetic resonance
imaging of the chest is a useful modality for diagnosis, because it is able
to distinguish between a bland thrombus and a tumor thrombus in the
pulmonary vein [6–8]. Treatment of PVT depends on the overall clinical
condition and comorbidity of the patient. There are no consensus
guidelines on optimal management of PVT, but anticoagulation is very
important even if there is no preferred duration and type of antic-
oagulant. It was also noticed in literatures that treating the underlying
pathology whether it was post-operative, tuberculosis, or malignancy
may lead to favorable outcomes in the pulmonary vein thrombosis. In
some cases of postoperative patients in whom anticoagulant was con-
traindicated, spontaneous lysis of small, untreated thrombi without
sequelae was observed. Thrombectomy has been successfully performed
when medical therapy fails. Lobectomy may be indicated when PVT is
complicated with massive hemoptysis or pulmonary necrosis [6,8,14].
Our patient was started with treatment with anti-tuberculosis medica-
tions and systemic anticoagulation. He responded to the treatment very
well but developed elevated liver enzymes secondary to the anti-TB
medications. The medications were discontinued to be restarted one by
one when the liver enzymes improve. Our patient was started with
heparin and warfarin and once he was therapeutic (INR=2–3), he was
continued with warfarin.
He needed a higher daily dose of warfarin (10mg) because of the
effect of rifampin on warfarin metabolism. Complications that can
occur after PVT include pulmonary infarction, pulmonary edema and
right ventricular failure. Peripheral embolism was also seen in literature
including limb ischemia, stroke, and renal infarction. Because of these
life and limb threatening complications, waiting for spontaneous lysis is
very risky and it is suggested to put patients on systemic antic-
oagulation and monitoring of the thrombus size in the coming months
[8].
4. Conclusion
Tuberculosis, both pulmonary and extrapulmonary, has been sug-
gested as an independent risk factor for thromboembolism due to a
hypercoagulable state induced by changes in clotting factors, protein C
and vascular endothelium. Pulmonary vein thrombosis can be seen in
patients with tuberculosis, lung transplantation, malignancy and post
radiofrequency catheter ablation. Presentation of patients is non-spe-
cific and needs a very high index of suspicion for proper diagnosis and
management to prevent further complications. Contrast enhanced CT
and trans esophageal echocardiogram are important for confirming the
diagnosis and evaluate atrial extension. Pulmonary vein thrombosis is
associated with limb and life-threatening complications and needs early
detection and treatment to prevent these complications. Systemic an-
ticoagulation, treatment of the predisposing pathology and monitoring
of the thrombosis are parts of management of pulmonary vein throm-
bosis.
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